Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by InvrsContrarianon Apr 02, 2021 11:46am
229 Views
Post# 32932029

Lillith

Lillith"He needs to clarify this right away so the market understands... It was a major shift that many did not see coming The call was not clear nor long enough to explain hence the sell off We need more detail and clarification on how he intends to reach the masses here" What was the major shift? Please look at all the marketing material released for the past year. The model is in plain sight. Patient has a need, Doctor has a solution, telehealth brings these two parties together, testing by stage, and then treatment. Covid exposed flaws such as mobile specimen collection. Check that obstacle off the list. New milestone achieved. So brother, so we add the last piece of that model ,the caring for the test positive consumer. What gives? What is so hard to understand that stage wants to buy a well established company that has been in the cancer business since 2013. He said there are incentives for them to perform, about 4 million shares up for grabs. Let the business people do business people stuff. Us retailers are along for the ride. Yesterday you could see the retail guy jumping ship, how many 10k, 15k share blocks were sold every 5 minutes because they can't understand a Direct to consumer product cash model. No change in cash model, just adding more revenue. For me increasing revenue is a sign post that states me in the face. And I'm smiling.
<< Previous
Bullboard Posts
Next >>